Benzinga | Aug 5, 2021 08:03AM EDT

Dyne Therapeutics Q2 EPS $(0.58) Up From $(3.31) YoY

Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(0.58) per share. This is a 82.48 percent increase over losses of $(3.31) per share from the same period last year.